Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
Phase 1
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002175
- Lead Sponsor
- The Honolulu Medical Group
- Brief Summary
To evaluate the efficacy of dinitrochlorobenzene (DNCB) in patients with early HIV infection by monitoring immunologic parameters and serum HIV RNA. To facilitate the understanding of possible alterations in the immunological status of the HIV+ patient cohort.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Queen Emma Clinics / The Queen's Med Ctr
🇺🇸Honolulu, Hawaii, United States
Queen Emma Clinics / The Queen's Med Ctr🇺🇸Honolulu, Hawaii, United States